Cedars-Science

March
28,
2024
| 06:30 AM America/Los_Angeles

In 2005, Paul Pharoah, PhD, MD, and colleagues organized a meeting in Cambridge, UK, to bring together researchers from around the world studying the genetics of ovarian cancer. It led to the creation of the

March
06,
2024
| 06:30 AM America/Los_Angeles

A new study by Cedars-Sinai investigators found that blocking a protein called interleukin-1-beta improved cardiac dysfunction and arrythmias in

March
01,
2024
| 09:58 AM America/Los_Angeles

Cedars-Sinai investigators have used artificial intelligence (AI) to help computers access some of the most important and difficult-to-mine information in cancer patients’ medical records: pathology reports. Their method, described in the

February
20,
2024
| 06:30 AM America/Los_Angeles

Patients who present with persistent atrial fibrillation at diagnosis are more likely to have certain risk factors as compared with patients with occasional atrial fibrillation (AFib). The findings, led by

February
19,
2024
| 06:30 AM America/Los_Angeles

The pain experienced by hospitalized patients with inflammatory bowel disease (IBD) is routinely treated with opioid medication, but with little success in actually controlling major discomfort. Cedars-Sinai investigators developed a

January
03,
2024
| 06:00 AM America/Los_Angeles

A new research study from the Smidt Heart Institute at Cedars-Sinai aimed to understand the possible connection between COVID-19 vaccination and a difficult-to-diagnose heart condition called postural orthostatic

December
21,
2023
| 06:45 AM America/Los_Angeles

New research from the Smidt Heart Institute at Cedars-Sinai found that women who developed signs of elevated blood pressure during pregnancy were more likely to have residual evidence of abnormal heart structure

December
15,
2023
| 07:00 AM America/Los_Angeles

New research from Cedars-Sinai’s Comprehensive Transplant Center found that a monoclonal antibody treatment reduced the risk of COVID-19 in a large group of solid organ transplant patients who were administered the

November
14,
2023
| 07:27 AM America/Los_Angeles

Investigators from the Board of Governors Regenerative Medicine Institute at Cedars-Sinai are advancing stem cell technology to treat degenerative diseases of the eye. In one recent study, they determined the